Sunday, March 8, 2015

ABC of Lung Cancer (ABC Series) Paperback – April 27,

Lung Cancer is the most common cause of cancer death and cancer symptoms. The ABC of Lung Cancer is a much needed reference for those treating and caring for patients with lung cancer such as primary care doctors, specialist cancer nurses, junior doctors, nurses, physiotherapists, radiographers and other health care professionals. This new title in the ABC series covers the epidemiology and diagnosis of lung cancer, focusing particularly on primary care issues such as what symptoms require urgent investigation, and when to refer to a specialist. This is a practical guide for all those involved in the care of the lung cancer patient, as well as patients and their families and carers.

GO TO STORE
ABC of Lung Cancer (ABC Series) Paperback – April 27,

Tumor Models in Cancer Research

Mesothelioma Tumor Models in Cancer Research (Cancer Drug Discovery and Development) [Kindle Edition]

Tumor Models in Cancer Research

Mesothelioma Advances in Surgical Pathology Mesothelioma Advances in Surgical Pathology

Purpose:Pathologists are frequently required to diagnose lung cancer. How they do so, as well as the subsequent testing that minute tissue often requires, is currently subject to modification. Treatment decisions hinge on the accurate typing of carcinoma, and nonsquamous non-small-cell lung carcinomas will often require molecular testing. It also has been proposed that the International Multidisciplinary Classification of Lung Adenocarcinoma include a more accurate and standardized terminology for pulmonary adenocarcinomas. To better understand and appropriately tackle all these changes, the authors have designed "a pragmatic tool for study and for practice."

Audience:The primary audience is pathologists and pathologists in training who deal with the day-to-day diagnosis of lung cancer or present to fellow clinicians at tumor boards. It also can be used for board examination study. Clearly, this is a good resource from established authorities on the subject, both as a guide for daily practice and as a means to be an informed participant at multidisciplinary conferences.

Features:The book deals fairly extensively with the histopathology of the various types of epithelial pulmonary malignancy, spanning carcinoid tumors, and common and unusual primary carcinomas and metastases. There are numerous images and subsections covering morphology, immunohistochemistry, and, importantly, the differential diagnosis. Current and proposed classifications and the clinical relevance of these diagnoses are elaborated. Precursor lesions are described in similar fashion. Issues with the current staging are discussed as well.

Molecular derangements, a topic currently at the forefront of pulmonary carcinoma, is dealt with via chapters on their methodology and predictive and prognostic significance. Evolving diagnostic and therapeutic modalities are also briefly touched on. As book deals with epithelial malignancies, it does not discuss benign tumors and nonepithelial malignancies.

READ MORE
Mesothelioma Advances in Surgical Pathology Mesothelioma Advances in Surgical Pathology

Mesothelioma Forecasting Product Liability Claims

Mesothelioma Forecasting Product Liability Claims Forecasting Product Liability Claims: Epidemiology and Modeling in the Manville Asbestos Case (Statistics for Biology and Health) Hardcover – October 25

From the reviews:
"This monograph shows then epidemiological prediction in action and is more eloquent than most textbooks as regards to methodology and difficulties encountered with field data. It should interest far outside the circle of asbestos-related epidemiology because of its rigorous exposition, the relevance of its questions, the adequacy of the solutions offered, the discussion of its results, and its legal, financial, and human consequences." Mathematical Population Studies, 12:181-182, 2005
"Over 750,000 claimants have filed suit … for illnesses and deaths related to exposure to asbestos, and at least 65 companies had been driven to bankruptcy; these numbers continue to grow. … This work led to substantial advances in the art of forecasting the number, timing, and nature of new claims. The authors present a lucid explanation of these advances and a description of how the matters in litigation have been settled. The presiding judge, Jack Weinstein, has contributed an informative preface … ." (J.C. Bailar, Short Book Reviews Publication of the International Statistical Institute, Vol. 25 (1), 2005)
"Demographers Eric Stallard, Kenneth Manton and Joel Cohen use a risk assessment framework to estimate the numbers of claims expected during the period between 1990 and 2049 for asbestos-related disease among men exposed to … asbestos products. … Forecasting Product Liability Claims is notable for its illustration of the possibility of using epidemiologic and demographic methods to develop models for broad policy purposes. … It is formula-rich and dense in its description of data sources and the machinery of the models, as it should be." (Jonathan M. Samet, Science-AAAS, May, 2006)
"This book summarizes the statistical models for projecting the number, timing, and nature of future claims, and it discusses how these predictions are used in developing a fair and equitable distribution of insufficient funds. … This book provides a fascinating account of how predication models are used to solve a very-real problem. It makes wonderful reading for statisticians interested in prediction problems, epidemiologists, actuaries, and lawyers involved in product liability suits and having to predict the number of possible litigants." (Johannes Ledolter, Zentralblatt MATH, Vol. 1099 (1), 2007)

READ MORE
Mesothelioma Forecasting Product Liability Claims

Mesothelioma Principles and Practice of Lung Cancer

Principles and Practice of Lung Cancer: The Official Reference Text of the International Association for the Study of Lung Cancer (IASLC)
Thoroughly revised and updated, this Fourth Edition is the most comprehensive, current reference on lung cancer, with contributions from the world's foremost surgeons, radiation oncologists, medical oncologists, pulmonologists, and basic scientists. Coverage includes complete information on combined modality treatments for small cell and non-small cell lung cancer and on complications of treatment and management of metastases. Emphasis is also given to early detection, screening, prevention, and new imaging techniques.

SEE MORE DETAIL
Mesothelioma Principles and Practice of Lung Cancer

Thursday, October 24, 2013

Surviving Mesothelioma and Other Cancers: A Patient's Guide